Lisata Therapeutics (NASDAQ:LSTA) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Lisata Therapeutics (LSTA) operate in?

Lisata Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Lisata Therapeutics Stock (NASDAQ: LSTA) stock price, news, charts, stock research, profile.

Open	$2.95
Close	-
Volume / Avg.	3.95K / 12.22K
Day Range	$2.90 - $2.99
52 Wk Range	2.00 - 3.83
Market Cap	$24.41M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	46
Short Interest	0.21%
Days to Cover	1.49

Recent News

Quest Diagnostics' Haystack Oncology Forges New MRD Deal

Quest Diagnostics' (NYSE: DGX) subsidiary, Haystack Oncology, and Lisata Therapeutics, Inc. (NASDAQ: LSTA) recently announced a research collaboration for using the Haystack MRD (minimal residual disease) technology.

Zacks

EXCLUSIVE: Haystack Oncology Inks Research Collaboration With Lisata Therapeutics To Use Haystack MRD Technology To Evaluate Pancreatic Cancer Therapy Efficacy

Haystack Oncology, a Quest Diagnostics company, and Lisata Therapeutics collaborate to use Haystack MRD technology in a study of certepetide plus chemotherapy for metastatic pancreatic cancer, focusing on detecting circulating tumor DNA.

Vandana Singh

Lisata Stock Rallies More Than 30% YTD: Here's Why

Lisata Therapeutics, Inc.'s (NASDAQ: LSTA) lead pipeline candidate is certepetide (formerly known as LSTA1), which is being developed for treating a range of solid tumors.

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jun

Jul

Aug

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$2.95
Close	-
Volume / Avg.	3.95K / 12.22K
Day Range	$2.90 - $2.99
52 Wk Range	2.00 - 3.83
Market Cap	$24.41M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	46
Short Interest	0.21%
Days to Cover	1.49

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Lisata Therapeutics (LSTA) stock?

You can purchase shares of Lisata Therapeutics (NASDAQ:LSTA) through any online brokerage.

View our list of the best stock brokerages

Who are Lisata Therapeutics (LSTA) competitors?

Other companies in Lisata Therapeutics’s space includes: Vincerx Pharma (NASDAQ:VINC), Lumos Pharma (NASDAQ:LUMO), Aligos Therapeutics (NASDAQ:ALGS), Bolt Biotherapeutics (NASDAQ:BOLT) and Gritstone Bio (NASDAQ:GRTS).

What is the forecast, or price target, for Lisata Therapeutics (LSTA) stock?

Lisata Therapeutics has a consensus price target of $15.00.

What is the current price for Lisata Therapeutics (LSTA)?

The stock price for Lisata Therapeutics (NASDAQ: LSTA) is $2.9 last updated October 2, 2024 at 12:57 PM EDT.

Does Lisata Therapeutics (LSTA) pay a dividend?

There are no upcoming dividends for Lisata Therapeutics.

When is Lisata Therapeutics (NASDAQ:LSTA) reporting earnings?

Lisata Therapeutics’s Q3 earnings are confirmed for Thursday, October 31, 2024.

Is Lisata Therapeutics (LSTA) going to split?

There is no upcoming split for Lisata Therapeutics.

What sector and industry does Lisata Therapeutics (LSTA) operate in?

Lisata Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Top Stock Ideas Sent Daily — Join and Gain Your Edge